Carol Tamminga
University of Texas Southwestern Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Carol Tamminga as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:09 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06257056 · Deep Brain Stimulation for PsychosisBradley Lega · recruiting · Treatment-Refractory Schizophrenia · principal investigator
- Ph4NCT04580134 · CLOZAPINE Response in Biotype-1University of Texas Southwestern Medical Center · recruiting · Schizophrenia, Schizoaffective Disorder, Bipolar 1 Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 8 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- 1/5 - Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)R01MH127179 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2022 to 2026 · $287,000 awarded in 2026Same name and institution; not confirmed by an ID
- 1/5 - Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)R01MH124813 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2021 to 2025 · $369,000 awarded in 2025Same name and institution; not confirmed by an ID
- Reverse Translation of Psychosis - associated Hippocampal Hyperactivity in the mouseR01MH123479 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2021 to 2025 · $410,000 awarded in 2025Same name and institution; not confirmed by an ID
- 1/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (B-SNIP 2) - ResuR01MH077851 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2007 to 2019 · $895,476 awarded in 2019Same name and institution; not confirmed by an ID
- Basic Science Training Program in the Neurobiology of Mental IllnessT32MH076690 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2007 to 2017 · $293,985 awarded in 2017Same name and institution; not confirmed by an ID
- Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)R01MH096913 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2013 to 2015 · $237,881 awarded in 2015Same name and institution; not confirmed by an ID
- Antipsychotic Influence on Altered MTL Neuronal Activity in SchizophreniaR01MH083957 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2009 to 2012 · $388,575 awarded in 2012Same name and institution; not confirmed by an ID
- Treating Cognition in SchizophreniaR34MH075863 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2007 to 2009 · $70,650 awarded in 2009Same name and institution; not confirmed by an ID
- Comparitive Antipsychotic Drug Actions on Brain NeurochemistryR01MH063439 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2003 to 2007 · $369,790 awarded in 2007Same name and institution; not confirmed by an ID
- Psychiatric Research Education Program(PREP)R25MH068338 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2006 to 2007 · $258,314 awarded in 2007Same name and institution; not confirmed by an ID
- Examination of the Limbic Cortex in SchizophreniaR01MH062236 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2002 to 2006 · $282,795 awarded in 2006Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:09 UTC. The ranking covers the 200 most relevant of 71 PubMed records, and a shared surname and initials can bring in a namesake. All 71 on PubMed
- Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.Neuropsychopharmacology · 1995709 citationsRCR 21.1
- Effects of ketamine in normal and schizophrenic volunteers.Neuropsychopharmacology · 2001508 citationsRCR 13.0
- Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.Science · 2011421 citationsRCR 10.6
- 334 citationsRCR 10.0
- Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.Am J Psychiatry · 1997266 citationsRCR 10.2
- Schizophrenic symptoms improve with apomorphine.Science · 1978213 citationsRCR 8.7
- Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.Am J Psychiatry · 1998182 citationsRCR 6.9
- Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.JAMA Psychiatry · 2024156 citationsRCR 30.5
- Clozapine in tardive dyskinesia: observations from human and animal model studies.J Clin Psychiatry · 1994128 citationsRCR 6.0
- Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.Am J Psychiatry · 1990120 citationsRCR 5.8